scispace - formally typeset
G

Gerd G. Gauglitz

Researcher at University of Texas Medical Branch

Publications -  22
Citations -  2133

Gerd G. Gauglitz is an academic researcher from University of Texas Medical Branch. The author has contributed to research in topics: Insulin resistance & Insulin. The author has an hindex of 15, co-authored 22 publications receiving 1930 citations. Previous affiliations of Gerd G. Gauglitz include Shriners Hospitals for Children - Galveston & University of Texas at Austin.

Papers
More filters
Journal ArticleDOI

Pathophysiologic response to severe burn injury.

TL;DR: It is concluded that the postburn response is profound, occurring in a timely manner, with derangements that are greater and more protracted than previously thought.
Journal ArticleDOI

A review of gene and stem cell therapy in cutaneous wound healing

TL;DR: Gene therapy, initially developed for treatment of congenital defects, is a new option for enhancing wound repair, and in order to accelerate wound closure, genes encoding for growth factors or cytokines showed the greatest potential.
Journal ArticleDOI

Burn size determines the inflammatory and hypermetabolic response

TL;DR: Morbidity and mortality in burned patients is burn size dependent, starts at a 60% TBSA burn and is due to an increased hypermetabolic and inflammatory reaction, along with impaired cardiac function.
Journal ArticleDOI

Gender differences in pediatric burn patients: does it make a difference?

TL;DR: Female burned patients exert an attenuated inflammatory and hypermetabolic response compared with males, which is reflected in improved muscle protein net balance and preservation of lean body mass, which are associated with shortened hospital stay.
Journal ArticleDOI

Abnormal Insulin Sensitivity Persists up to Three Years in Pediatric Patients Post-Burn

TL;DR: A severe burn is associated with stress-induced insulin resistance that persists not only during the acute phase but also for up to 3 yr post-burn, indicating peripheral and whole body insulin resistance.